These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21884791)

  • 1. Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids.
    Gårevik N; Strahm E; Garle M; Lundmark J; Ståhle L; Ekström L; Rane A
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):295-300. PubMed ID: 21884791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
    Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
    PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.
    Deshmukh N; Petróczi A; Barker J; Székely AD; Hussain I; Naughton DP
    Subst Abuse Treat Prev Policy; 2010 Apr; 5():7. PubMed ID: 20429943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes.
    Christou GA; Christou MA; Žiberna L; Christou KA
    Eur J Sport Sci; 2019 Oct; 19(9):1276-1286. PubMed ID: 30880613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor rs2228570 polymorphism is associated with LH levels in men exposed to anabolic androgenic steroids.
    Björkhem-Bergman L; Lehtihet M; Rane A; Ekström L
    BMC Res Notes; 2018 Jan; 11(1):51. PubMed ID: 29351807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical health and fitness of an elite bodybuilder during 1 year of self-administration of testosterone and anabolic steroids: a case study.
    Alén M; Häkkinen K
    Int J Sports Med; 1985 Feb; 6(1):24-9. PubMed ID: 3921472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of single-dose nandrolone decanoate on gonadotropins, blood lipids and HMG CoA reductase in healthy men.
    Gårevik N; Börjesson A; Choong E; Ekström L; Lehtihet M
    Andrologia; 2016 Jun; 48(5):595-600. PubMed ID: 26370185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers.
    Urhausen A; Torsten A; Wilfried K
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):369-75. PubMed ID: 12711025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment.
    Wesson DW; McGinnis MY
    Pharmacol Biochem Behav; 2006 Mar; 83(3):410-9. PubMed ID: 16603236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of serum inhibin B as a potential marker of testosterone doping in weight lifting men.
    Barthel A; Bornstein SR; Benker G
    Clin J Sport Med; 2010 Mar; 20(2):117-9. PubMed ID: 20215894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men.
    Gårevik N; Rane A; Björkhem-Bergman L; Ekström L
    Subst Abuse Rehabil; 2014; 5():121-7. PubMed ID: 25525405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users.
    Souza FR; Dos Santos MR; Porello RA; Fonseca GWPD; Sayegh ALC; Lima TP; Ferreira FD; Oliveira TF; Yonamine M; Takayama L; Pereira RMR; Negrão CE; Passarelli M; Rochitte CE; Alves MJNN
    Atherosclerosis; 2019 Apr; 283():100-105. PubMed ID: 30826541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
    Dickerman RD; McConathy WJ; Zachariah NY
    J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of anabolic androgenic steroids abuse.
    Bonetti A; Tirelli F; Catapano A; Dazzi D; Dei Cas A; Solito F; Ceda G; Reverberi C; Monica C; Pipitone S; Elia G; Spattini M; Magnati G
    Int J Sports Med; 2008 Aug; 29(8):679-87. PubMed ID: 18004690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.